ArticleCancer cell international2024
Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinib.
Bei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it